Appistry Announces Pipeline Challenge Competition to Reward Creative Solutions for NGS Analysis
News Jul 08, 2014
Appistry, Inc. today launched its inaugural Appistry Pipeline Challenge. The competition will provide $70,000 of software and hardware to aid one team in developing and executing an innovative next-generation sequencing (NGS) analysis pipeline. Any U.S.-based researcher in any organization is eligible to enter the competition, which runs from July 7–August 15, 2014.
“If we’ve learned anything while helping our customers implement production-grade pipelines—pipelines capable of being used reliably and repeatedly in a controlled, clinical setting—it’s that they are difficult to build,” said Dr. Rich Mazzarella, chief scientific officer at Appistry and one of the judges for the Appistry Pipeline Challenge. “It requires expertise in everything from bioinformatics to high-performance computing, and not everyone has access to resources that can streamline development and deployment. Appistry is leveling the playing field by spurring creativity and helping one team transform its innovative idea into a solution that can drive clinical research and genomically enhanced medicine.”
The prize package from Appistry comprises an one-year license to commercial versions of industry-leading NGS analysis tools from the Broad Institute, which includes the Genome Analysis Toolkit (GATK), MuTect, ContEst, and Somatic Indel Detector; and Appistry’s Ayrris® On Ramp Program for NGS analysis, which provides a developer workstation with installed software for managing tools, data, and pipelines; preconfigured analysis tools and starter pipelines; and eight hours of training from Appistry.
A panel of judges will determine the competition’s winner based on the quality of the overall entry; the need for a solution to the problem the project addresses; the innovation displayed in the tools selected and their use in the pipeline; and the impact the solution will have on clinical research or precision medicine. The winner will be announced on August 28, 2014.
Appistry will enable potential entrants to learn more about the Appistry Pipeline Challenge and ask questions during a live webinar on Thursday, July 24, 2014; register by visiting https://www1.gotomeeting.com/register/693194248. More information about the Appistry Pipeline Challenge is available at appistry.com/contest, or by following the contest at #PickMyPipeline on Twitter.
Scientists at McGill have found the answer to a question that perplexed Charles Darwin; if natural selection works at the level of the individual, fighting for survival and reproduction, how can a single colony produce worker ants that are so dramatically different in size – from “minor” workers to large-headed soldiers with huge mandibles – especially if they are sterile?
Scientists have developed a successful method to make truly personalized predictions of future disease outcomes for patients with certain types of chronic blood cancers. The study combined extensive genetic and clinical information to predict the prognosis for patients with myeloproliferative neoplasms.
For centuries, gardeners have attempted to breed blue roses with no success. But now, thanks to modern biotechnology, the elusive blue rose may finally be attainable. Researchers have found a way to express pigment-producing enzymes from bacteria in the petals of a white rose, tinting the flowers blue.
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019
2nd World Congress on Genetics & Genetic Disorders
May 13 - May 14, 2019